JohnO'NeillMD

Physician

Dr. O'Neill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Albert Einstein Healthcare NetworkResidency, Urology, 2022 - 2027
Lewis Katz School of Medicine at Temple UniversityClass of 2022
Franklin and Marshall CollegeBA, Biochemistry and Molecular Biology, Cum Laude, 2011 - 2015

PubMed

102 citations
Immune‐Related Adverse Events as a Biomarker in Non‐Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors
Julia Judd, Matthew Zibelman, Elizabeth Handorf, John O'Neill, Chethan Ramamurthy
The Oncologist. 2017-10-01
2 citations
Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial
Matthew Zibelman, Aeen M. Asghar, Daniel C. Parker, John O'Neill, Shuanzeng Wei
The Journal of Urology. 2021-02-04
53 citations
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Benjamin Miron, Jean H. Hoffman-Censits, Fern Anari, John O'Neill, Daniel M. Geynisman
European Urology Oncology. 2020-03-10

Journal Articles

The onset of embryo maturation in Arabidopsis is determined by its developmental stage and does not depend on endosperm cellularization
O’Neill JP, Colon KT, Jenik PD, The Plant Journal, 3/22/2019